Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11070204 | 0.85 | KDM4E (0.54) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL5730634 | 0.83 | ALDH1A1 (0.62) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL4551259 | 0.82 | HPGD (0.57) | ALDH1A1HPGDCYP3A4NPC1RAB9A | |
| SCHEMBL28220170 | 0.81 | NPC1 (0.49) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL8995796 | 0.80 | LMNA (0.40) | ALDH1A1HPGDNPC1RAB9AHSD17B10 | |
| SCHEMBL687106 | 0.80 | KDM4E (0.53) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL5567273 | 0.79 | FLT1 (0.48) | ALDH1A1HPGDCYP3A4MAPK1KMT2A | |
| SCHEMBL11365669 | 0.79 | PLG (0.42) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| Hydrochloric Acid SCHEMBL6382403 | 0.78 | CYP1A2 (0.44) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL27876023 | 0.78 | TSHR (0.57) | ALDH1A1HPGDCYP3A4MAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724107-A2 | OPHTHALMIC FILMS | Fount Bio, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024254278-A9 | OPHTHALMIC FILMS | FOUNT BIO, INC. (US) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024254278-A2 | OPHTHALMIC FILMS | FOUNT BIO, INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| EP-3514822-B1 | METHOD FOR MANUFACTURING FIELD EFFECT TRANSISTOR AND METHOD FOR MANUFACTURING WIRELESS COMMUNICATION DEVICE | TORAY INDUSTRIES (JP) | 2023-04-26 | — | — | EP | disclosed |
| US-20220175819-A1 | DELIVERY AND RETENTION OF ACTIVE AGENTS WITHIN THE SKIN | FOUNT BIO, INC. | 2022-06-09 | — | — | US | disclosed |
| EP-3955887-A1 | DELIVERY AND RETENTION OF ACTIVE AGENTS WITHIN THE SKIN | Fount Bio, Inc. (US) | 2022-02-23 | — | — | EP | disclosed |
| US-11094899-B2 | Method for manufacturing field effect transistor and method for manufacturing wireless communication device | TORAY INDUSTRIES, INC. | 2021-08-17 | — | — | US | disclosed |
| EP-3367402-B1 | CAPACITOR, METHOD FOR MANUFACTURING SAME, AND WIRELESS COMMUNICATION DEVICE USING SAME | TORAY INDUSTRIES (JP) | 2021-07-07 | — | — | EP | disclosed |
| WO-2020214889-A1 | DELIVERY AND RETENTION OF ACTIVE AGENTS WITHIN THE SKIN | FOUNT BIO, INC. (US) | 2020-10-22 | — | — | WO | disclosed |
| US-10636866-B2 | Capacitor, method for manufacturing same, and wireless communication device using same | TORAY INDUSTRIES, INC. (JP) | 2020-04-28 | — | — | US | disclosed |
| WO-2012064429-A2 | SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-18 | — | — | WO | disclosed |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100160331-A1 | NOVEL CARBAMOYLOXY ARYLALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND | SK HOLDINGS CO. LTD. (KR) | 2010-06-24 | — | — | US | disclosed |
| US-5554617-A | Method for treating cancer with 6-aryl pyrimidine compounds | THE UPJOHN COMPANY (US) | 1996-09-10 | — | — | US | disclosed |
| US-5434157-A | Active against herpes, hepatitis, papovavirus | THE UPJOHN COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
| US-5002951-A | 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent | THE UPJOHN COMPANY (US) | 1991-03-26 | — | — | US | disclosed |
| US-4665077-A | IMMUNOREGULATORY AGENTS | THE UPJOHN COMPANY (US) | 1987-05-12 | — | — | US | disclosed |
| US-4619933-A | 6-aryl pyrimidines for treating aplastic anemia | THE UPJOHN COMPANY (US) | 1986-10-28 | — | — | US | disclosed |
| US-4543248-A | Method for immunoregulation with 6-aryl pyrimidine compounds | THE UPJOHN COMPANY (US) | 1985-09-24 | — | — | US | disclosed |
| US-4507302-A | Method for treating arthritis with 6-aryl pyrimidine compounds | THE UPJOHN COMPANY (US) | 1985-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160331-A1 | NOVEL CARBAMOYLOXY ARYLALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND | HTR5A, OPRD1, OPRL1 | ALDH1A1 137/4885HPGD 1003/4885CYP3A4 473/4885 |
| US-20220175819-A1 | DELIVERY AND RETENTION OF ACTIVE AGENTS WITHIN THE SKIN | MMP8, MMP7, MMP1 | ALDH1A1 1788/4885HPGD 862/4885CYP3A4 4437/4885 |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | PUF60, TST, MPST | ALDH1A1 1432/4885HPGD 1999/4885CYP3A4 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.